Evidence map›Paper›PMID 31281947›Full record

ArticleJournal of neurovirology2019

Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction.

Jyoti Barokar, Allen McCutchan, Reena Deutsch, Bin Tang, Mariana Cherner, Ajay R Bharti

Open access · greenAbstract read
In one paragraph

Article in Journal of neurovirology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Observational
  3. Serum albumin and white matter hyperintensities.Translational psychiatry · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jyoti BarokarDepartment of Psychiatry, University of California, San Diego, CA, USA.
Allen McCutchanDivision of Infectious Diseases, Department of Medicine, University of California, San Diego, CA, 92093, USA.
Reena DeutschDepartment of Psychiatry, University of California, San Diego, CA, USA.
Bin TangDepartment of Psychiatry, University of California, San Diego, CA, USA.
Mariana ChernerDepartment of Psychiatry, University of California, San Diego, CA, USA.
Ajay R BhartiDivision of Infectious Diseases, Department of Medicine, University of California, San Diego, CA, 92093, USA. abharti@ucsd.edu.ORCID 0000-0002-4807-3351
University of California San Diego · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Impact of HCV Therapy on CNS OutcomesR01DA039775 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BHARTI, AJAY R · 2015 to 2019
$3.0M
Neurocognitive Effects of HCV, HIV, and Drug UseR01DA016015 · NIDA · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI LETENDRE, SCOTT L · 2002 to 2004
$1.2M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIDA NIH HHS R01 DA016015NIDA NIH HHS R01 DA039775
6 · The paper itself

Abstract

Infections with HIV and hepatitis C virus (HCV) can individually and jointly contribute to neurocognitive impairment (NCI). Rates of NCI in HIV/HCV-coinfected persons range from 40 to 63% but its correlates have not been described. In this study, we examined HIV/HCV-coinfected adults on antiretroviral therapy (ART) with undetectable HIV RNA in blood (n = 412) who were assessed using a comprehensive neuropsychological test battery. Demographics, host and viral biomarkers, and markers of liver dysfunction were compared between impaired (n = 198) and unimpaired (n = 214) participants using logistic regression. The cohort was predominantly middle-aged men, half of whom (48%) had NCI. The odds of NCI increased by almost two-fold when serum albumin was < 4 g/dL, 1.7-fold when alanine aminotransferase (ALT) levels were > 50 IU/L, and 2.2-fold with every unit increase in log

Indexed as

Cognitive DysfunctionCoinfectionFemaleHepacivirusHepatitis CHIV InfectionsHumansLiverLiver Function TestsMaleMiddle AgedAPRIHepatic inflammationHIV/HCV coinfectionLiver fibrosisNeurocognitive impairment

Identifiers

PMID31281947
PMCPMC6923581
OpenAlexW2954814918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.